My Shocking Ozempic Journey: A Type 1 Diabetic's Weight-Loss Struggle

2025-08-15 00:00:23.009

The author, a 46-year-old woman, has struggled with her weight since age 11, using food for comfort and engaging in cycles of overeating and self-shame. Diagnosed with type 2 diabetes at 27, she underwent various weight loss attempts, including therapy, exercise, and different programs, losing 50 pounds but remaining overweight. A subsequent diagnosis revealed she actually had type 1 diabetes. After years of managing her condition, her doctor prescribed Ozempic, initially off-label, for weight loss. While it improved her blood sugar control, she didn't lose weight. As Ozempic gained popularity, she faced shortages and switched to Mounjaro, still without weight loss. The author discusses the high expectations surrounding GLP-1 drugs, noting that a significant percentage of users don't experience significant weight loss. She highlights the psychological impact of being a 'non-responder,' the societal pressure to achieve weight loss, and the need to shift focus from weight to overall health and well-being. She advocates for self-acceptance and a healthier relationship with food, emphasizing that the true value of GLP-1 medications might be overlooked due to the focus on weight loss alone. The author concludes by expressing gratitude for the blood sugar control provided by GLP-1s and her hope to cultivate a more positive relationship with food.